PLoS ONE 5 , e9644 (2010)
This is why aggressive, fast-paced detoxification is highly contraindicated for complex chronic illness patients
Back to Journals Clinical, Cosmetic and Investigational Dermatology Volume 12 The Effectiveness of a New Topical Formulation Containing GSH-C4 and Hyaluronic Acid in Seborrheic Dermatitis: Preliminary Results of an Exploratory Pilot Study Authors Campione E, Mazzilli S, Lanna C , Cosio T , Palumbo V, Cesaroni G , Lozzi F , Diluvio L , Bianchi L Received 17 September 2019 Accepted for publication 6 November 2019 Published 16 December 2019 Volume 2019:12 Pages 881885 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Jeffrey Weinberg Elena Campione, Sara Mazzilli, Caterina Lanna, Terenzio Cosio, Vincenzo Palumbo, Gaia Cesaroni, Flavia Lozzi, Laura Diluvio, Luca Bianchi Dermatologic Unit, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy Correspondence: Elena Campione Dermatologic Unit, Department of Systems Medicine, University of Rome Tor Vergata, Viale Oxford 81, Rome 00133, Italy Tel +39 0620902743 Email [email protected] Introduction: Seborrheic dermatitis is a common skin disease with clinical aspects similar to those of psoriasis, eczema or allergic reactions, appearing on the sebum-rich areas of the scalp, face, and trunk
We welcome clients who reside in the Rochester, Troy, Auburn Hills, and Stony Creek communities
Each vial contains 5mg of lyophilized BPC-157
